History

Business Segments

• Speciality Chemicals:This segment includes a wide range of products such as Nitro Chloro Benzenes (NCBs), Di-chloro Benzenes (DCBs), Benzyl Products, Pharmaceutical Intermediates, and Performance Products. These products are used in a variety of industries, including pharmaceuticals, agrochemicals, polymers, additives, pigments, and dyes.

• Pharmaceuticals:This segment includes Active Pharmaceutical Ingredients (APIs) and Intermediates. Aarti Industries manufactures APIs for a wide range of therapeutic purposes, including anti-hypertensive, anti-asthmatic, anti-cancer, central nervous system (CNS) agents, skincare, decongestants, anti-thalassemic, analgesic, and ophthalmologic.
• Performance Products:This segment includes products such as Fluorine Specialities, Pharmaceutical Excipients, and Food Additives. These products are used in a variety of industries, including pharmaceuticals, food and beverages, and personal care.

Subsidiaries of Aarti Industries

1. Aarti Corporate Services Limited:ACSL is a wholly owned subsidiary of Aarti Industries Limited. It offers a range of corporate services to Aarti Industries and its other subsidiaries, including accounting, finance, taxation, legal, and human resources.
2. Innovative Envirocare Jhagadia Limited:It is a wholly owned subsidiary of Aarti Industries Limited. It is one of the foremost provider of environmental services in India. The company offers a wide range of services, including hazardous waste management, wastewater treatment, and air pollution control.
3. Aarti Polychem Private Limited:This is a wholly owned subsidiary of Aarti Industries Limited. It is a manufacturer of speciality chemicals, including polyurethane intermediates, plasticizers, and other performance products. The organization's products are used in a variety of industries, including automotive, construction, and packaging.

Key Personnel

1. Rajendra V. Gogri, Chairman and Managing Director

Corporate Actions

1. On June 22, 2021, Aarti Industries Limited announced a bonus issue in a 1:1 ratio.
2. On September 30, 2019, Aarti Industries Limited announced a bonus issue in a 1:1 ratio.

1. On January 5, 2018, the Board of Directors approved a buyback of up to 2,75,000 fully paid-up equity shares with a face value of ₹10 each. This represented approximately 1.15% of the organization's total equity shares.
2. The organization approved another buyback on November 2, 2016, as the record date. It involves up to 3,60,000 fully paid-up equity shares with a face value of ₹10 each. This represented around 1.49% of the total number of Equity Shares.

1. Aarti Industries approved a demerger plan on June 28, 2018, separating its Home & Personal Care Segment into Arti Surfactants Limited and Nascent Chemical Industries Limited into Aarti Surfactants. Shareholders of Aarti Industries received one share in Aarti Surfactants for every ten shares held.
2. On October 20, 2022, Aarti Industries announced another demerger with Aarti Pharmalabs Limited. Shareholders received one fully paid-up equity share of the resulting organization for every four shares held in the Aarti Industries.

• The organization expects a demand-supply gap due to declining demands, leading to margin pressure over the short term in FY23-24. This gap could affect the organization's profit margins and financial performance.
• Aarti Industries Limited foresees an improvement gradually in the second half of the financial year FY23-24. The organization is planning for a recovery from the prevalent macroeconomic concerns, with expectations of a gradual improvement in enterprise conditions.
• The organization emphasises investing in R&D for products targeting various emerging sectors, such as sustainable and green solutions, battery chemicals, electronics chemicals, and high-end polymers. These investments indicate potential future revenue streams but might impact short-term profitability due to R&D expenses.
• Aarti Industries Limited remains confident in its long-term growth prospects by core prioritying on innovation, continuous process enhancements, and new value chains. The organization's commitment to innovation might positively impact future revenue and market positioning over the long term.